Dabradx (Dabrafenib) 75mg | Generic BRAF Inhibitor | BigBear Pharmaceutical Co., Ltd. | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Dabradx is a generic formulation of dabrafenib made by BigBear Pharmaceutical in Laos. It delivers the 75 mg dose of this BRAF inhibitor in capsule form as a lower-priced alternative to the Novartis originator, aimed at patients and institutions that need ongoing BRAF-targeted treatment without the originator's cost.

Generic Information: Dabradx (Dabrafenib)

BigBear Pharmaceutical Co., Ltd. is a Lao manufacturer that has become a recognized source of affordable oncology generics for regional export. The company runs GMP-compliant production and ships a catalog of targeted-cancer medicines, of which Dabradx is the dabrafenib line. Its Lao facilities are among the region's suppliers serving patients who otherwise face limited access to newer oncology drugs.

What Is Dabradx (Dabrafenib) Used For?

Dabradx is indicated for tumors carrying a BRAF V600 mutation. The core uses are unresectable or metastatic melanoma and, in combination with the MEK inhibitor trametinib, BRAF V600E-mutated metastatic non-small cell lung cancer and anaplastic thyroid cancer.

How Does Dabradx Work?

The dabrafenib in Dabradx selectively inhibits mutant BRAF kinase, cutting off the MAPK growth signal that BRAF-mutant cancer cells depend on. This slows tumor growth and may promote cancer-cell death; pairing it with trametinib strengthens the effect by blocking the pathway at two points.

Indications

  • BRAF V600-mutant unresectable or metastatic melanoma
  • Adjuvant melanoma therapy with trametinib
  • BRAF V600E metastatic NSCLC with trametinib
  • BRAF V600E anaplastic thyroid cancer with trametinib

Dosage & Administration

The standard adult regimen is 150 mg twice daily, or two 75 mg capsules per dose, with or without food. Swallow whole with water. Dose reductions are managed by the treating oncologist.

Side Effects

Common reactions include fever, fatigue, rash, nausea, headache, chills and joint pain. Serious risks include new primary skin cancers, bleeding, cardiomyopathy, uveitis and hyperglycemia. Regular skin and temperature monitoring is part of treatment.

Storage & Handling

Store at room temperature in the original packaging, away from moisture and light, out of children's reach, and not past expiry.

Why Choose Dabradx?

  • BigBear generic — affordable dabrafenib from a Lao GMP manufacturer.
  • Same dosing as originator — 75 mg capsules for the standard 150 mg twice-daily regimen.
  • Export-friendly — GLT handles documentation and logistics worldwide.

How to Order Dabradx from GLT

  1. Reach GLT at WhatsApp +86 15234153837 or email [email protected] with quantity and destination.
  2. Receive a quotation and delivery estimate.
  3. Pay through Hao Yi Lian / 好易联.
  4. Goods ship with documentation and tracking.

A valid prescription may be requested before dispatch. Institutions and individual patients are both served.

FAQ

1. Who manufactures Dabradx?

Dabradx is made by BigBear Pharmaceutical Co., Ltd. in Laos.

2. Is Dabradx bioequivalent to Tafinlar?

It is a generic dabrafenib containing the same 75 mg active ingredient and is dosed identically.

3. Do I need a prescription?

Yes, dabrafenib is prescription-only, and a prescription may be requested before dispatch.

Related Oncology Products

Palutini (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Trans Continental Life Science & Pharmaceuticals (TLPH) (Laos) — an...

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

Baricent (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Incepta Pharmaceuticals Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Incepta Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to Olumiant...

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

Barinat (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Natco Pharma Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Natco Pharma Limited (India) — an affordable alternative to Olumiant...